Blend Labs (BLND)
(Delayed Data from NYSE)
$3.91 USD
-0.07 (-1.76%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $3.91 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for Blend Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 137 | 354 | 547 | 152 | 0 |
Receivables | 18 | 23 | 34 | 15 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 15 | 19 | 32 | 19 | 0 |
Total Current Assets | 170 | 396 | 613 | 186 | 0 |
Net Property & Equipment | 4 | 6 | 6 | 5 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2 | 2 | 4 | 5 | 0 |
Intangibles | 2 | 2 | 460 | 1 | 0 |
Deposits & Other Assets | 19 | 15 | 14 | 6 | 0 |
Total Assets | 206 | 433 | 1,112 | 216 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 1 | 6 | 3 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 6 | 10 | 18 | 9 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 24 | 24 | 36 | 23 | 0 |
Total Current Liabilities | 32 | 35 | 60 | 35 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 138 | 217 | 214 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 5 | 13 | 3 | 0 |
Minority Interest (Liabilities) | 46 | 41 | 36 | 0 | 0 |
Total Liabilities | 225 | 310 | 338 | 52 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 385 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,322 | 1,287 | 1,218 | 51 | 0 |
Retained Earnings | -1,342 | -1,163 | -443 | -273 | 0 |
Other Equity | 0 | -1 | -1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -19 | 123 | 775 | 163 | 0 |
Total Liabilities & Shareholder's Equity | 206 | 433 | 1,112 | 216 | 0 |
Total Common Equity | -19 | 123 | 775 | -222 | 0 |
Shares Outstanding | 249.90 | 225.00 | 217.00 | NA | NA |
Book Value Per Share | -0.08 | 0.55 | 3.57 | 0.00 | 0.00 |
Fiscal Year End for Blend Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 113 | 128 | 137 | 245 | 266 |
Receivables | 20 | 18 | 18 | 20 | 21 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 10 | 13 | 15 | 19 | 22 |
Total Current Assets | 143 | 160 | 170 | 283 | 309 |
Net Property & Equipment | 8 | 6 | 4 | 4 | 5 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2 | 2 | 2 | 2 | 2 |
Intangibles | 2 | 2 | 2 | 2 | 2 |
Deposits & Other Assets | 24 | 24 | 19 | 17 | 21 |
Total Assets | 185 | 202 | 206 | 318 | 351 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 2 | 2 | 2 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 5 | 6 | 10 | 5 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 37 | 35 | 24 | 25 | 27 |
Total Current Liabilities | 42 | 43 | 32 | 37 | 35 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 139 | 138 | 219 | 218 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 2 | 3 | 4 | |
Minority Interest (Liabilities) | 183 | 48 | 46 | 45 | 43 |
Total Liabilities | 231 | 238 | 225 | 312 | 309 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,336 | 1,326 | 1,322 | 1,318 | 1,312 |
Retained Earnings | -1,382 | -1,362 | -1,342 | -1,311 | -1,270 |
Other Equity | 0 | 0 | 0 | 0 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -45 | -36 | -19 | 6 | 41 |
Total Liabilities & Shareholder's Equity | 185 | 202 | 206 | 318 | 351 |
Total Common Equity | -45 | -36 | -19 | 6 | 41 |
Shares Outstanding | 254.20 | 252.30 | 249.90 | 247.90 | 245.80 |
Book Value Per Share | -0.18 | -0.14 | -0.08 | 0.03 | 0.17 |